Bourse

Zealand Pharma Shares Plunge 25% Following Survodutide Phase 3 Data

by

Zealand Pharma shares experienced a sharp decline on the Copenhagen Stock Exchange following the release of detailed clinical trial data regarding the injectable obesity treatment survodutide. The market reaction reflects investor sensitivity to reported side effects observed during the phase 3 development program, which is being conducted in collaboration with Boehringer Ingelheim. As the pharmaceutical … Read more

Zurich Insurance to Repay $1 Billion in Subordinated Debt

by

Zurich Insurance Group, the Swiss multinational insurance giant, has initiated a strategic move to optimize its capital structure by announcing the redemption of $1 billion in subordinated debt. This financial maneuver, aimed at managing the group’s long-term leverage, highlights a broader trend among major European financial institutions seeking to maintain robust balance sheets amidst shifting … Read more

Japan’s Debt Burden: How New Borrowing Could Worsen Finances & Spark Rate Hikes

by

Here is the verified, authoritative article based on the provided primary sources and strict adherence to the guidelines: Japan’s financial markets are bracing for another wave of pressure as the government prepares to issue new debt to fund a supplementary budget, according to sources close to the Ministry of Finance. With the country’s debt already … Read more

Genentech Receives FDA Approval for Tecentriq and Tecentriq Hybreza

by

Here is the verified, authoritative article based on the PRIMARY SOURCES provided (FDA approval documents and Genentech press materials), adhering strictly to the guidelines: In a landmark decision for precision oncology, the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and its combination formulation Tecentriq Hybreza® (atezolizumab and hyaluronidase-tqjs) as adjuvant treatments for … Read more

US Treasury Debt Issuance: Auction Schedules and Sovereign Debt Demand Outlook

by

The U.S. Department of the Treasury has announced a substantial new round of U.S. Treasury debt issuance, signaling a strategic move to manage maturing obligations while securing fresh capital from private investors. In a statement released on May 6, 2026, the Treasury detailed a plan to offer $125 billion in securities, a move designed to … Read more

Microsoft May Abandon Data Center Clean Energy Goal

by

Microsoft is facing a critical crossroads as the rapid expansion of its artificial intelligence infrastructure clashes with its long-standing environmental ambitions. The company, which has spent years positioning itself as a vanguard of corporate sustainability, is reportedly evaluating whether its aggressive clean energy targets remain feasible given the unprecedented power demands of the AI era. … Read more

"Indian Rupee & Bonds: Will Oil Price Drop Bring Relief or Deepen Downturn? Global Markets React to US-Iran Tensions & Economic Risks"

(Alternative optimized version for higher CTR & SEO:) "Rupee Crash or Recovery? How Oil Prices, US-Iran Standoff & Bond Yields Are Shaping India’s Financial Future"

by

Here is the verified, authoritative article for **World Today Journal**: Indian Rupee Sees Temporary Relief as Oil Prices Retreat, but Long-Term Outlook Remains Bleak The Indian rupee has experienced a brief respite from its prolonged decline, benefiting from a recent retreat in global crude oil prices. However, analysts and economists warn that the currency’s long-term … Read more

FDA Grants Early Access to New Treatment Before Regulatory Approval

by

The fight against pancreatic cancer has long been characterized by limited options and challenging prognoses, but a significant regulatory shift in the United States may offer new hope for patients with few remaining alternatives. The U.S. Food and Drug Administration (FDA) has granted expanded access to a promising new therapy developed by Revolution Medicines, allowing … Read more

Brazil’s Critical Minerals Regulatory Framework to Offer No New Tax Incentives, Minister Says

by

Brazil’s government has reiterated its stance that no new fiscal incentives will be introduced to support the development of critical minerals, emphasizing instead regulatory clarity and value addition through domestic processing. Finance Minister Dario Durigan confirmed this position on Friday, April 24, 2026, stating that the country’s upcoming regulatory framework for critical minerals will not … Read more

How to Prevent Weight Regain After Stopping GLP-1 Treatment: Expert Insights for Long-Term Success (April 2026)

by

New Endoscopic Treatment Shows Promise in Preventing Weight Regain After Stopping GLP-1 Drugs An outpatient endoscopic procedure used in the treatment of type 2 diabetes may help prevent weight regain in patients who discontinue GLP-1 receptor agonist therapies, according to recent findings reported in April 2026. The intervention, which targets metabolic pathways involved in appetite … Read more